These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31615011)

  • 21. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
    Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
    Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A urinary microRNA (miR) signature for diagnosis of bladder cancer.
    Hofbauer SL; de Martino M; Lucca I; Haitel A; Susani M; Shariat SF; Klatte T
    Urol Oncol; 2018 Dec; 36(12):531.e1-531.e8. PubMed ID: 30322728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
    Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnostic values of circulating miRNAs for hypertension and bioinformatics analysis.
    Zhang X; Wang X; Wu J; Peng J; Deng X; Shen Y; Yang C; Yuan J; Zou Y
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29961674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. microRNA expression profiles as decision-making biomarkers in the management of bladder cancer.
    Amir S; Mabjeesh NJ
    Histol Histopathol; 2017 Feb; 32(2):107-119. PubMed ID: 27586262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
    Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
    Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring biomarkers in the overactive bladder: Alterations in miRNA levels of a panel of genes in patients with OAB.
    Fırat E; Aybek Z; Akgün Ş; Küçüker K; Akça H; Aybek H
    Neurourol Urodyn; 2019 Aug; 38(6):1571-1578. PubMed ID: 31157926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA Expression Profiles in Upper Tract Urothelial Carcinoma Differentiate Tumor Grade, Stage, and Survival: Implications for Clinical Decision-Making.
    Browne BM; Stensland KD; Patel CK; Sullivan T; Burks EJ; Canes D; Raman JD; Warrick J; Reiger-Christ KM
    Urology; 2019 Jan; 123():93-100. PubMed ID: 30315887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer.
    Moisoiu T; Dragomir MP; Iancu SD; Schallenberg S; Birolo G; Ferrero G; Burghelea D; Stefancu A; Cozan RG; Licarete E; Allione A; Matullo G; Iacob G; Bálint Z; Badea RI; Naccarati A; Horst D; Pardini B; Leopold N; Elec F
    Mol Med; 2022 Apr; 28(1):39. PubMed ID: 35365098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
    Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
    BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
    Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
    Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
    Chi Q; Wang ZY; Li HY; Song DB; Xu H; Ma G; Wang ZM; Li XM
    Chin Med J (Engl); 2019 Oct; 132(19):2354-2361. PubMed ID: 31567382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and clinical significance of microRNA-21-3p and microRNA-551-5p in patients with acute pancreatitis].
    Wu K; Wang L; Fu G; Zheng Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):463-467. PubMed ID: 32527354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer.
    El Ahanidi H; El Azzouzi M; Hafidi Alaoui C; Tetou M; Bensaid M; Chaoui I; Benbacer L; Hassan I; Oukabli M; Michaud K; Ameur A; Al Bouzidi A; El Mzibri M; Jandus C; Attaleb M
    Front Oncol; 2021; 11():795242. PubMed ID: 35223454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
    Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.